- Industry | - Sector | Mr. Paul D. Anderson B.Com., C.A. CEO | TSX Exchange | CA40390B1094 ISIN |
Australia Country | 4,329 Employees | - Last Dividend | - Last Split | - IPO Date |
Healius Limited is an Australian company specialized in providing a diverse range of specialty diagnostic services to both consumers and practitioners. With its operations segmented into Pathology, Imaging, and Others, the company has established a significant presence in the healthcare sector in Australia. Initially known as Primary Health Care Limited, it rebranded to Healius Limited in December 2018, highlighting a period of growth and transformation. Since its inception in 1994, Healius Limited has been committed to delivering high-quality healthcare services, focusing on diagnostics and specialized medical procedures, across its extensive network.
Diagnostic Imaging Services: Healius offers a wide range of diagnostic imaging services, vital for accurate disease diagnosis and patient management. These services encompass traditional X-rays, ultrasounds, MRIs, and CT scans.
Pathology Services: Through several renowned brands including Laverty Pathology, Dorevitch Pathology, and QML Pathology, Healius provides extensive pathology services that cover routine blood tests, histopathology, cytology, and specialized genetic testing among others.
Specialized Medical Procedures: The company caters to a variety of specialized medical needs through its brands, offering services like cataract surgery, colonoscopy, gastroscopy, and more. Notably, Healius delves into areas such as plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery, ensuring comprehensive care.
Veterinary Diagnostic Services: Expanding beyond human healthcare, Healius also serves the veterinary sector through Vetpath Laboratory, Vetnostics, QML Vetnostics, and more, providing crucial diagnostics and pathology services for animals.
Genomic Diagnostics: Under brands like Genomic Diagnostic, Healius is at the forefront of offering advanced genomic testing, crucial for understanding genetic disorders and tailoring personalized treatment plans.
Gastrointestinal Diagnostics: Through Gastrolab, the company offers specialized diagnostics for gastrointestinal disorders, aiding in the effective treatment of digestive system conditions.
Research and Development Services: Agilex Biolabs, another brand under Healius, signifies the company's involvement in the research and development sector, focusing particularly on the pharmaceutical and biotechnological fields.